Evidence map›Paper›PMID 31169918›Full record

ArticleEpilepsia2019

High health care costs in minority groups of older US Medicare beneficiaries with epilepsy.

Maria Pisu, Joshua Richman, Jerzy P Szaflarski, Ellen Funkhouser, Chen Dai, Lucia Juarez, Edward Faught, Roy C Martin

Open access · greenAbstract read
In one paragraph

Article in Epilepsia, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.8field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 12 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Maria PisuDivision of Preventive Medicine, University of Alabama at Birmingham, Birmingham, Alabama.ORCID 0000-0001-9329-3268
Joshua RichmanDepartment of Surgery, University of Alabama at Birmingham, Birmingham, Alabama.
Jerzy P SzaflarskiDepartment of Neurology, University of Alabama at Birmingham, Birmingham, Alabama.
Ellen FunkhouserDivision of Preventive Medicine, University of Alabama at Birmingham, Birmingham, Alabama.
Chen DaiCenter for Health Service Research, University of Kentucky, Lexington, Kentucky.
Lucia JuarezDivision of Preventive Medicine, University of Alabama at Birmingham, Birmingham, Alabama.
Edward FaughtDepartment of Neurology, Emory University, Atlanta, Georgia.
Roy C MartinDepartment of Neurology, University of Alabama at Birmingham, Birmingham, Alabama.
University of Alabama at Birmingham · USEmory University · USUniversity of Kentucky · US

Funding

Quality of Epilepsy Treatment and Costs in Older Americans by Race (QUIET CARE)R01NS080898 · NINDS · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI PISU, MARIA · 2012 to 2014
$1.1M
NINDS NIH HHS 1RO1NS080898-01NINDS NIH HHS R01 NS080898
6 · The paper itself

Abstract

objectiveTo examine health care costs in diverse older Medicare beneficiaries with epilepsy.

methodsUsing 2008-2010 claims data, we conducted a longitudinal cohort study of a random sample of Medicare beneficiaries augmented for minority representation. Epilepsy cases (n = 36 912) had ≥1 International Classification of Diseases, Ninth Edition (ICD-9) 345.x or ≥2 ICD-9 780.3x claims, and ≥1 antiepileptic drug (AED) in 2009; new cases (n = 3706) had no seizure/epilepsy claims nor AEDs in the previous 365 days. Costs were measured by reimbursements for all care received. High cost was defined as follow-up 1-year cost ≥ 75th percentile. Logistic regressions examined association of high cost with race/ethnicity, adjusting for demographic, clinical, economic, and treatment quality factors. In cases with continuous 2-year data, we obtained costs in two 6-month periods before and two after the index event.

resultsCohort was ~62% African Americans (AAs), 11% Hispanics, 5% Asians, and 2% American Indian/Alaska Natives. Mean costs in the follow-up were ~$30 000 (median = $11 547; new cases, mean = $44 642; median = $25 008). About 19% white compared to 27% AA cases had high cost. AA had higher odds of high cost in adjusted analyses (odds ratio [OR] = 1.20, 95% confidence interval [CI] = 1.11-1.29), although this was only marginally significant when adjusting for AED adherence (OR = 1.09, 95% CI = 1.01-1.18, P = 0.03). Factors associated with high cost included ≥1 comorbidity, neurological care, and low AED adherence. Costs were highest at ~$17 000 in the 6 months immediately before and after the index event (>$29 000 for new cases). SIGNIFICANCE: The financial sequelae of epilepsy among older Americans disproportionally affect minorities. Studies should examine contributors to high costs.

Indexed as

AgedAged, 80 and overEpilepsyEthnicityFemaleHealth Care CostsHumansLogistic ModelsLongitudinal StudiesMaleMedicareMinority GroupsRacial GroupsUnited StatescostsepilepsyMedicareolder adultsquality of careseizure

Identifiers

PMID31169918
PMCPMC6685539
OpenAlexW2956126598

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.